Gyre Therapeutics Statistics

Total Valuation

GYRE has a market cap or net worth of $1.30 billion. The enterprise value is $1.26 billion.

Market Cap	1.30B
Enterprise Value	1.26B

Important Dates

The next estimated earnings date is Wednesday, August 21, 2024, after market close.

Earnings Date	Aug 21, 2024
Ex-Dividend Date	n/a

Share Statistics

GYRE has 85.51 million shares outstanding. The number of shares has increased by 30.00% in one year.

Shares Outstanding	85.51M
Shares Change (YoY)	+30.00%
Shares Change (QoQ)	+55.84%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.22
Forward PS	n/a
PB Ratio	22.89
P/FCF Ratio	48.09
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	8.95
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	46.71

Financial Position

The company has a current ratio of 3.22, with a Debt / Equity ratio of 0.00.

Current Ratio	3.22
Quick Ratio	3.02
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	0.01
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -2,139.50% and return on invested capital (ROIC) is -104.26%.

Return on Equity (ROE)	-2,139.50%
Return on Assets (ROA)	-131.30%
Return on Capital (ROIC)	-104.26%
Revenue Per Employee	$237,137
Profits Per Employee	-$144,454
Employee Count	593
Asset Turnover	2.16
Inventory Turnover	n/a

Taxes

In the past 12 months, GYRE has paid $11.05 million in taxes.

Income Tax	11.05M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +174.29% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+174.29%
50-Day Moving Average	12.41
200-Day Moving Average	15.18
Relative Strength Index (RSI)	67.52
Average Volume (20 Days)	101,668

Short Selling Information

The latest short interest is 173,599, so 0.20% of the outstanding shares have been sold short.

Short Interest	173,599
Short Previous Month	189,075
Short % of Shares Out	0.20%
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GYRE had revenue of $140.62 million and -$85.66 million in losses. Loss per share was -$1.53.

Revenue	140.62M
Gross Profit	135.01M
Operating Income	-59.34M
Pretax Income	-74.61M
Net Income	-85.66M
EBITDA	-72.66M
EBIT	-74.61M
Loss Per Share	-$1.53

Full Income Statement

Balance Sheet

The company has $37.35 million in cash and $275,000 in debt, giving a net cash position of $37.08 million or $0.43 per share.

Cash & Cash Equivalents	37.35M
Total Debt	275,000
Net Cash	37.08M
Net Cash Per Share	$0.43
Equity (Book Value)	56.64M
Book Value Per Share	0.66
Working Capital	43.24M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $34.99 million and capital expenditures -$8.03 million, giving a free cash flow of $26.96 million.

Operating Cash Flow	34.99M
Capital Expenditures	-8.03M
Free Cash Flow	26.96M
FCF Per Share	$0.32

Full Cash Flow Statement

Margins

Gross margin is 96.01%, with operating and profit margins of -42.20% and -60.92%.

Gross Margin	96.01%
Operating Margin	-42.20%
Pretax Margin	-53.06%
Profit Margin	-60.92%
EBITDA Margin	-51.67%
EBIT Margin	-53.06%
FCF Margin	19.17%

Dividends & Yields

GYRE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.00%
Shareholder Yield	-30.00%
Earnings Yield	-6.61%
FCF Yield	2.08%

Dividend Details

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on October 31, 2023. It was a reverse split with a ratio of 1:15.

Last Split Date	Oct 31, 2023
Split Type	Reverse
Split Ratio	1:15

Scores

GYRE has an Altman Z-Score of 22.06 and a Piotroski F-Score of 4.

Altman Z-Score	22.06
Piotroski F-Score	4